Published in Food and Drug Law Weekly, May 23rd, 2008
"We made significant progress with our clinical program during the first quarter of this year, as we reported additional positive results from our Phase 3 studies for Puricase(R) (pegloticase) for treatment-failure gout," said...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Food and Drug Law Weekly